Recent Posts
Categories
Tag Archives: Insmed
UPDATE 2-FDA lifts hold on trials of Insmed lung drug, shares up
May 7 (Reuters) – Insmed Inc can resume the development of its key drug Arikace after the U.S. health regulator lifted a second clinical hold on the drugmaker’s experimental treatment for lung disease, sending its shares up 47 percent.